Press Release
Press Release
Press Contacts: Erik Cummins, Matt Hyams, Taina Rosa, Olivia Meyer
10.03.25
Pillsbury advised Thyme Care, the leading value-based cancer care enabler, in its $97 million Series D fundraise, bringing the company’s total capital raised to $275 million.
Thyme Care collaborates with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes and reduced total cost of care. Thyme Care’s approach combines a technology-enabled Care Team and seamless integration with providers, creating a hybrid collaborative care model that guides and supports the entire patient journey.
Click here to learn more.
The Pillsbury deal team was led by Corporate partner and Digital Health practice leader Ron Fleming and included senior associate Taylor O’Toole and associates Sarah Konnerth, Alec Saccogna and Alexander Ntchobo.